<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-20741" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Pacemaker Types and Selection</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Lak</surname>
            <given-names>Hassan Mehmood</given-names>
          </name>
          <aff>Cleveland Clinic Foundation</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Goyal</surname>
            <given-names>Amandeep</given-names>
          </name>
          <aff>University of Kansas Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Hassan Mehmood Lak declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Amandeep Goyal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>11</day>
          <month>12</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-20741.s1" sec-type="Definition/Introduction">
        <title>Definition/Introduction</title>
        <p content-type="pubmed-excerpt">Pacemakers are electric activity-generating devices used to treat patients with slow heart rates or symptomatic heart blocks and in patients with heart failure.<xref ref-type="bibr" rid="article-20741.r1">[1]</xref> All cardiac pacemakers are generally composed of a pulse generator that generates the electrical current required for stimulation of heart musculature and&#x000a0;1 or&#x000a0;2 electrodes (also referred to as leads), which are responsible for transmitting the electrical activity generated by the pulse generator to the heart musculature.<xref ref-type="bibr" rid="article-20741.r2">[2]</xref><xref ref-type="bibr" rid="article-20741.r3">[3]</xref></p>
      </sec>
      <sec id="article-20741.s2" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>
<bold>Common Indications for Pacemaker Placement</bold>
</p>
        <list list-type="order">
          <list-item>
            <p>Sinus node dysfunction (Class I indication)<xref ref-type="bibr" rid="article-20741.r4">[4]</xref></p>
          </list-item>
          <list-item>
            <p>Acquired AV block</p>
          </list-item>
          <list-item>
            <p>Post myocardial infarction<xref ref-type="bibr" rid="article-20741.r5">[5]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Less Common Indications</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Congenital complete heart block</p>
          </list-item>
          <list-item>
            <p>Long QT syndrome</p>
          </list-item>
          <list-item>
            <p>Hypertrophic cardiomyopathy<xref ref-type="bibr" rid="article-20741.r6">[6]</xref><xref ref-type="bibr" rid="article-20741.r7">[7]</xref></p>
          </list-item>
          <list-item>
            <p>Heart failure</p>
          </list-item>
        </list>
        <p>
<bold>Conditions in Which Cardiac Pacing is Not Indicated</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Syncope of undetermined etiology</p>
          </list-item>
          <list-item>
            <p>Sinus bradycardia without significant symptoms</p>
          </list-item>
          <list-item>
            <p>Sinoatrial block or sinus arrest without significant symptoms</p>
          </list-item>
          <list-item>
            <p>Asymptomatic prolonged PR intervals with atrial fibrillation</p>
          </list-item>
          <list-item>
            <p>Asymptomatic bradycardia during sleep</p>
          </list-item>
          <list-item>
            <p>Asymptomatic 2nd-degree Mobitz I (Wenckebach ) AV block</p>
          </list-item>
          <list-item>
            <p>Right bundle branch block with left axis deviation without syncope or other symptoms compatible with intermittent AV block</p>
          </list-item>
          <list-item>
            <p>Reversible AV blocks, such as those with electrolyte abnormalities, Lyme disease, sleep apnea</p>
          </list-item>
        </list>
        <p>
<bold>Pacemaker Related Complications</bold>
</p>
        <p><bold>Pacemaker Syndrome: </bold>Pacemaker syndrome is a disease that represents the clinical consequences of suboptimal atrioventricular (AV) synchrony or AV dyssynchrony, regardless of the pacing mode after pacemaker implantation.</p>
        <p>Symptoms of Pacemaker Syndrome are:</p>
        <list list-type="bullet">
          <list-item>
            <p>Cannon A-waves</p>
          </list-item>
          <list-item>
            <p>Chest pain</p>
          </list-item>
          <list-item>
            <p>Confusion</p>
          </list-item>
          <list-item>
            <p>Dizziness</p>
          </list-item>
          <list-item>
            <p>Fatigue</p>
          </list-item>
          <list-item>
            <p>Palpitations</p>
          </list-item>
          <list-item>
            <p>Shortness of breath</p>
          </list-item>
          <list-item>
            <p>Syncope</p>
          </list-item>
        </list>
        <p>Other complications associated with Pacemakers include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Pneumothorax</p>
          </list-item>
          <list-item>
            <p>Cardiac perforation</p>
          </list-item>
          <list-item>
            <p>Significant pocket hematoma</p>
          </list-item>
          <list-item>
            <p>Lead dislodgement</p>
          </list-item>
          <list-item>
            <p>Venous thrombosis and obstruction</p>
          </list-item>
          <list-item>
            <p>Mechanical lead complications</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20741.s3" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>
<bold>Pacemaker Types&#x000a0;and Systems</bold>
</p>
        <p>Pulse Generators:&#x000a0; These are the "battery" component of the pacemaker, which normally produces the electrical activity required to transmit to the heart musculature. Pulse generators are currently placed most commonly in the infraclavicular region of the anterior chest wall.</p>
        <p><bold>Transvenous Systems</bold>: Most cardiac pacing systems use transvenous electrodes to transmit electrical impulses from the pulse generator to the heart musculature.</p>
        <p><bold>Epicardial systems</bold>&#x000a0;work by direct stimulation through the pulse generator by attaching directly to the heart's surface. They are less common use nowadays, and transvenous pacing has completely replaced them.</p>
        <p><bold>Leadless systems</bold>: There have been some innovations in developing leadless systems due to some limitations with transvenous and epicardial pacing systems.<xref ref-type="bibr" rid="article-20741.r8">[8]</xref><xref ref-type="bibr" rid="article-20741.r9">[9]</xref><xref ref-type="bibr" rid="article-20741.r10">[10]</xref>&#x000a0;</p>
        <p>
<bold>Types of Pacemakers</bold>
</p>
        <p>There are&#x000a0;3 basic kinds of pacemakers:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Single chamber</bold>. One lead attaches to the upper or lower heart chamber.</p>
          </list-item>
          <list-item>
            <p><bold>Dual-chamber</bold>. Uses&#x000a0;2 leads,&#x000a0;1 for the upper and&#x000a0;1 for the lower chamber</p>
          </list-item>
          <list-item>
            <p><bold>Biventricular pacemakers</bold> (used in cardiac resynchronization therapy).&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Modes of Cardiac Pacing</bold>
</p>
        <p>
<bold>The modes of pacemakers are based on a generic code known as NBG (combined from NASPE/BPEG) and typically consist of 5 letters.<xref ref-type="bibr" rid="article-20741.r11">[11]</xref></bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Letter 1. In the area being paced, A stands for atria, V stands for Ventricle, D stands for Dual, O stands for none</p>
          </list-item>
          <list-item>
            <p>Letter 2. For the area that is sensed,&#x000a0;A stands for atria, V stands for Ventricle, D stands for Dual, O stands for none</p>
          </list-item>
          <list-item>
            <p>Letter 3. The response of the pacemaker to sensing: O stands for none, I stands for inhibiting, T stands for triggering, D stands for dual</p>
          </list-item>
          <list-item>
            <p>Letter 4. Rate adaptiveness. O stands for none, and R stands for rate adaptiveness.</p>
          </list-item>
        </list>
        <p>The&#x000a0;modes are explainable by dividing them into categories of a single chamber or dual chamber:</p>
        <p>
<bold>Single Chamber Modes</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>
<bold>VOO</bold>
</p>
          </list-item>
        </list>
        <p>V- Pacing in the ventricle</p>
        <p>O- Sensing is OFF</p>
        <p>O- Response to sensing is OFF</p>
        <p>In this mode, the pacemaker paces at a programmed rate regardless of the heart's intrinsic electrical activity.</p>
        <list list-type="bullet">
          <list-item>
            <p>
<bold>VVI</bold>
</p>
          </list-item>
        </list>
        <p>V- Pacing in the ventricle</p>
        <p>V- Sensing in the ventricle</p>
        <p>I-Inhibit</p>
        <p>In this mode, the pacemaker can sense the electrical activity and withhold pacing when not required.</p>
        <list list-type="bullet">
          <list-item>
            <p>
<bold>AOO&#x000a0;&#x000a0;</bold>
</p>
          </list-item>
        </list>
        <p>A- Pacing in the atrium</p>
        <p>O- Sensing is OFF</p>
        <p>O- Response to sensing is OFF</p>
        <p>In this mode, the pacemaker paces at a programmed rate regardless of the heart's intrinsic electrical activity.</p>
        <list list-type="bullet">
          <list-item>
            <p>
<bold>AAI</bold>
</p>
          </list-item>
        </list>
        <p>&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;A- Pacing in the atrium</p>
        <p>&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;A- Sensing in the atrium</p>
        <p>&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;I- Inhibit</p>
        <p>In this mode, the pacemaker can adapt to the intrinsic atrial rate and should be able to pace when needed and inhibit when not required.</p>
        <p>
<bold>Dual Chamber Modes</bold>
</p>
        <p>Dual Chamber Modes can further subdivide into Tracking Modes and Non-Tracking modes.</p>
        <p>
<bold>Tracking Modes</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>
<bold>DDD</bold>
</p>
          </list-item>
        </list>
        <p>D- Pacing in the atrium and ventricle</p>
        <p>D- Sensing in the atrium and ventricle</p>
        <p>D- Inhibit and or trigger</p>
        <p>Intrinsic P-wave and QRS can inhibit pacing, and intrinsic P-wave or atrial pace can trigger an AV delay. This mode fully adapts to intrinsic heart rhythm and mimics normal conduction as much as possible.</p>
        <p>DDD has&#x000a0;4 distinct pacing patterns:</p>
        <list list-type="order">
          <list-item>
            <p>AsVs (Atrial sensed Ventricle sensed): Used when the patient has good sinus node function and good AV node function</p>
          </list-item>
          <list-item>
            <p>AsVp (Atrial sensed Ventricular paced): Used when the patient has a good sinus node function but poor AV node conduction</p>
          </list-item>
          <list-item>
            <p>ApVs (Atrial paced Ventricular sensed): Used when the patient has poor sinus node function but has intact AV node conduction</p>
          </list-item>
          <list-item>
            <p>ApVp (Atrial paced Ventricular paced): Used when the patient has poor sinus and AV node function.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>
<bold>VDD</bold>
</p>
          </list-item>
        </list>
        <p>V- Pacing in the ventricle</p>
        <p>D- Sensing in the atrium and ventricle</p>
        <p>D- Inhibit and or trigger</p>
        <p>Intrinsic QRS can inhibit ventricular pacing, and Intrinsic P-wave can trigger an AV delay. In this mode,&#x000a0;one cannot pace the atrium, but an intrinsic atrial activity can trigger an AV delay, resulting in P-wave tracking and possibly maintaining AV synchrony. The primary issue with VDD programming mode is that if the sinus node function drops below the pacemaker's programmed lower rate, it causes AV dissociation due to the inability to pace in the atrium. VDD mode should only be used in patients with good SA node function. It might be used when the patient has a high pacing threshold in the atrium. This way, the pacemaker can sense in the atrium, maintain AV synchrony, and not waste battery life by pacing in the high threshold atrium.</p>
        <p>
<bold>Non-Tracking Modes</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>
<bold>DDI</bold>
</p>
          </list-item>
        </list>
        <p>D - Pacing in the atrium and ventricle</p>
        <p>D - Sensing in the atrium and ventricle</p>
        <p>I - Response to that sensing be to either pace or inhibit</p>
        <p>This mode's primary use is in patients with atrial tachyarrhythmias and mode switch algorithms. DDI mode results in AV dissociation if the atrial rate exceeds the set rate. P wave tracking is excellent for AV synchrony; however, if the patient goes into atrial fibrillation with a rapid heart rate,&#x000a0;one does not want to track the atrium and pace the ventricle at a high rate.</p>
        <list list-type="bullet">
          <list-item>
            <p>
<bold>DOO</bold>
</p>
          </list-item>
        </list>
        <p>D- Pacing in the atrium and ventricle</p>
        <p>O- Sensing is OFF</p>
        <p>O- Response to that sensing is OFF</p>
        <p>This mode results in AV sequential pacing at the lower rate limit regardless of the heart's intrinsic activity. DOO mode is asynchronous pacing and is usually used only in certain situations, such as when a magnet is placed over a pacemaker or sometimes when a patient is having surgery.</p>
        <p>
<bold>R- Rate Response</bold>
</p>
        <p>Rate Response or Rate Adaptive Pacing is used in patients with chronotropic incompetence. Chronotropic incompetence is defined as the heart's inability to appropriately increase its rate with increased activity or metabolic demand, leading to exercise intolerance. Usually, there is a problem with the SA node function. The pacemaker utilizes its sensing ability with sensors that can sense motion or minute ventilation changes according to the activity and pace the heart at a required rate.</p>
        <p>
<bold>Choosing a Pacing Mode</bold>
</p>
        <p>While selecting a pacemaker mode,&#x000a0;the clinician wants to ensure that the patient has a viable atrial activity. If the atrium is healthy,&#x000a0;the clinician wants to maintain AV synchrony as much as possible. The first important question is whether the sinus node function is intact.</p>
        <p>If sinus node function is not intact and the patient has atrial arrhythmias:</p>
        <p>&#x000a0;<bold>Chronic Atrial Arrhythmias, e.g., Atrial Fibrillation or Atrial Flutter:</bold></p>
        <list list-type="bullet">
          <list-item>
            <p>If the patient is chronotropically incompetent, the mode of choice is VVIR.</p>
          </list-item>
          <list-item>
            <p>If the patient is chronotropically competent, the mode of choice is VVI.</p>
          </list-item>
        </list>
        <p>&#x000a0;<bold>Paroxysmal Atrial Arrhythmias:</bold></p>
        <list list-type="bullet">
          <list-item>
            <p>If the patient is chronotropically incompetent, the mode of choice is DDDR.</p>
          </list-item>
          <list-item>
            <p>If the patient is chronotropically competent, the mode of choice is DDD.</p>
          </list-item>
        </list>
        <p>If the sinus node is intact and the patient has normal sinus rhythm or sinus bradycardia:</p>
        <p>
<bold>Intact AV Node conduction</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>If the patient is chronotropically incompetent, the mode of choice is AAIR.</p>
          </list-item>
          <list-item>
            <p>If the patient is chronotropically competent, the mode of choice is AAI.</p>
          </list-item>
        </list>
        <p><bold>AV Node conduction not Intact:</bold>&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>If the patient is chrontropically incompetent, the mode of choice&#x000a0;is DDDR.</p>
          </list-item>
          <list-item>
            <p>If the patient is chronotropically competent, the mode of choice is DDD.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20741.s4" sec-type="Nursing, Allied Health, and Interprofessional Team Interventions">
        <title>Nursing, Allied Health, and Interprofessional Team Interventions</title>
        <p>Pacemakers are implanted when the intrinsic electrical activity of the heart is either dyssynchronous or the patient has symptomatic episodes resulting from the asynchronous electrical impulse stimulated from the SA node. As mentioned above, different pacemaker types and modes are available, and the interprofessional team's closed-loop monitoring and deep and close monitoring of these modes are of the utmost importance in managing patients with cardiac pacemakers.</p>
      </sec>
      <sec id="article-20741.s5">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20741&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20741">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/20741/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=20741">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-20741.s6">
        <title>References</title>
        <ref id="article-20741.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kusumoto</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Schoenfeld</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Barrett</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Edgerton</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Ellenbogen</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Gold</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Goldschlager</surname>
                <given-names>NF</given-names>
              </name>
              <name>
                <surname>Hamilton</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Joglar</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Marine</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>McLeod</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Oken</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Patton</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Pellegrini</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Selzman</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Varosy</surname>
                <given-names>PD</given-names>
              </name>
            </person-group>
            <article-title>2018 ACC/AHA/HRS Guideline on the&#x000a0;Evaluation and Management of&#x000a0;Patients With Bradycardia and Cardiac&#x000a0;Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2019</year>
            <month>Aug</month>
            <day>20</day>
            <volume>74</volume>
            <issue>7</issue>
            <fpage>e51</fpage>
            <page-range>e51-e156</page-range>
            <pub-id pub-id-type="pmid">30412709</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20741.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nelson</surname>
                <given-names>GD</given-names>
              </name>
            </person-group>
            <article-title>A brief history of cardiac pacing.</article-title>
            <source>Tex Heart Inst J</source>
            <year>1993</year>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>12</fpage>
            <page-range>12-8</page-range>
            <pub-id pub-id-type="pmid">8508058</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20741.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Verma</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Knight</surname>
                <given-names>BP</given-names>
              </name>
            </person-group>
            <article-title>Update in Cardiac Pacing.</article-title>
            <source>Arrhythm Electrophysiol Rev</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>8</volume>
            <issue>3</issue>
            <fpage>228</fpage>
            <page-range>228-233</page-range>
            <pub-id pub-id-type="pmid">31463061</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20741.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brignole</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Auricchio</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Baron-Esquivias</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bordachar</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Boriani</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Breithardt</surname>
                <given-names>OA</given-names>
              </name>
              <name>
                <surname>Cleland</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Deharo</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Delgado</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Elliott</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Gorenek</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Israel</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Leclercq</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Linde</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mont</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Padeletti</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sutton</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Vardas</surname>
                <given-names>PE</given-names>
              </name>
              <collab>ESC Committee for Practice Guidelines (CPG)</collab>
              <name>
                <surname>Zamorano</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Achenbach</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Baumgartner</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bax</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Bueno</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Dean</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Deaton</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Erol</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fagard</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ferrari</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hasdai</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hoes</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Kirchhof</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Knuuti</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kolh</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lancellotti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Linhart</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nihoyannopoulos</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Piepoli</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Ponikowski</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sirnes</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Tamargo</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Tendera</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Torbicki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wijns</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Windecker</surname>
                <given-names>S</given-names>
              </name>
              <collab>Document Reviewers</collab>
              <name>
                <surname>Kirchhof</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Blomstrom-Lundqvist</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Badano</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>Aliyev</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>B&#x000e4;nsch</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Baumgartner</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bsata</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Buser</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Charron</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Daubert</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Dobreanu</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Faerestrand</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hasdai</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hoes</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Le Heuzey</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Mavrakis</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>McDonagh</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Merino</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Nawar</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Nielsen</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Pieske</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Poposka</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ruschitzka</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Tendera</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Van Gelder</surname>
                <given-names>IC</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).</article-title>
            <source>Eur Heart J</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>34</volume>
            <issue>29</issue>
            <fpage>2281</fpage>
            <page-range>2281-329</page-range>
            <pub-id pub-id-type="pmid">23801822</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20741.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>O'Gara</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Kushner</surname>
                <given-names>FG</given-names>
              </name>
              <name>
                <surname>Ascheim</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Casey</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>de Lemos</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Ettinger</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Fang</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Fesmire</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Franklin</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Granger</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Krumholz</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Linderbaum</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Morrow</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Newby</surname>
                <given-names>LK</given-names>
              </name>
              <name>
                <surname>Ornato</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Ou</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Radford</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Tamis-Holland</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Tommaso</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Tracy</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Woo</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>DX</given-names>
              </name>
            </person-group>
            <article-title>2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2013</year>
            <month>Jan</month>
            <day>29</day>
            <volume>61</volume>
            <issue>4</issue>
            <fpage>e78</fpage>
            <page-range>e78-e140</page-range>
            <pub-id pub-id-type="pmid">23256914</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20741.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>Authors/Task Force members</collab>
              <name>
                <surname>Elliott</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Anastasakis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Borger</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Borggrefe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cecchi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Charron</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hagege</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Lafont</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Limongelli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mahrholdt</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>McKenna</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Mogensen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nihoyannopoulos</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Nistri</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pieper</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Pieske</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Rapezzi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rutten</surname>
                <given-names>FH</given-names>
              </name>
              <name>
                <surname>Tillmanns</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Watkins</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).</article-title>
            <source>Eur Heart J</source>
            <year>2014</year>
            <month>Oct</month>
            <day>14</day>
            <volume>35</volume>
            <issue>39</issue>
            <fpage>2733</fpage>
            <page-range>2733-79</page-range>
            <pub-id pub-id-type="pmid">25173338</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20741.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gersh</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Maron</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Bonow</surname>
                <given-names>RO</given-names>
              </name>
              <name>
                <surname>Dearani</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Fifer</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Link</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Naidu</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Nishimura</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Ommen</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Rakowski</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Seidman</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Towbin</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Udelson</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Yancy</surname>
                <given-names>CW</given-names>
              </name>
              <collab>American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines</collab>
              <collab>American Association for Thoracic Surgery</collab>
              <collab>American Society of Echocardiography</collab>
              <collab>American Society of Nuclear Cardiology</collab>
              <collab>Heart Failure Society of America</collab>
              <collab>Heart Rhythm Society</collab>
              <collab>Society for Cardiovascular Angiography and Interventions</collab>
              <collab>Society of Thoracic Surgeons</collab>
            </person-group>
            <article-title>2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.</article-title>
            <source>Circulation</source>
            <year>2011</year>
            <month>Dec</month>
            <day>13</day>
            <volume>124</volume>
            <issue>24</issue>
            <fpage>2761</fpage>
            <page-range>2761-96</page-range>
            <pub-id pub-id-type="pmid">22068435</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20741.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Auricchio</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Delnoy</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Butter</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Brachmann</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Van Erven</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Spitzer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Moccetti</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Seifert</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Markou</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Laszo</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Regoli</surname>
                <given-names>F</given-names>
              </name>
              <collab>Collaborative Study Group</collab>
            </person-group>
            <article-title>Feasibility, safety, and short-term outcome of leadless ultrasound-based endocardial left ventricular resynchronization in heart failure patients: results of the wireless stimulation endocardially for CRT (WiSE-CRT) study.</article-title>
            <source>Europace</source>
            <year>2014</year>
            <month>May</month>
            <volume>16</volume>
            <issue>5</issue>
            <fpage>681</fpage>
            <page-range>681-8</page-range>
            <pub-id pub-id-type="pmid">24497573</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20741.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reddy</surname>
                <given-names>VY</given-names>
              </name>
              <name>
                <surname>Knops</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Sperzel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Petru</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sediva</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>de Groot</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Tjong</surname>
                <given-names>FV</given-names>
              </name>
              <name>
                <surname>Jacobson</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ostrosff</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dukkipati</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Koruth</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Wilde</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Kautzner</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Neuzil</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Permanent leadless cardiac pacing: results of the LEADLESS trial.</article-title>
            <source>Circulation</source>
            <year>2014</year>
            <month>Apr</month>
            <day>08</day>
            <volume>129</volume>
            <issue>14</issue>
            <fpage>1466</fpage>
            <page-range>1466-71</page-range>
            <pub-id pub-id-type="pmid">24664277</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20741.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Knops</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Tjong</surname>
                <given-names>FV</given-names>
              </name>
              <name>
                <surname>Neuzil</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sperzel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Petru</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sediva</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>de Groot</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Dukkipati</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Koruth</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Wilde</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Kautzner</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Reddy</surname>
                <given-names>VY</given-names>
              </name>
            </person-group>
            <article-title>Chronic performance of a leadless cardiac pacemaker: 1-year follow-up of the LEADLESS trial.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2015</year>
            <month>Apr</month>
            <day>21</day>
            <volume>65</volume>
            <issue>15</issue>
            <fpage>1497</fpage>
            <page-range>1497-504</page-range>
            <pub-id pub-id-type="pmid">25881930</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20741.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bernstein</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Daubert</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Fletcher</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Hayes</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>L&#x000fc;deritz</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Reynolds</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Schoenfeld</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Sutton</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The revised NASPE/BPEG generic code for antibradycardia, adaptive-rate, and multisite pacing. North American Society of Pacing and Electrophysiology/British Pacing and Electrophysiology Group.</article-title>
            <source>Pacing Clin Electrophysiol</source>
            <year>2002</year>
            <month>Feb</month>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>260</fpage>
            <page-range>260-4</page-range>
            <pub-id pub-id-type="pmid">11916002</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
